ReP USP - Resultado da busca

Artigo de periodico
Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia?: a systematic review and meta-analysis (2025)
Hassib, Lucas; Kanashiro, Alexandre ; Pedrazzi, João Francisco Cordeiro; Vercesi, Bárbara Ferreira ; Higa, Sayuri; Arruda, Íris; Soares, Yago; Souza, Adriana de Jesus de; Jordão Junior, Alceu Afonso ; Guimarães, Francisco Silveira ; Ferreira, Frederico Rogério
Source: Brain, Behavior, and Immunity - Health. Unidade: FMRP
Subjects: ESQUIZOFRENIA, PROBIÓTICOS, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HASSIB, Lucas et al. Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia?: a systematic review and meta-analysis. Brain, Behavior, and Immunity - Health, v. 43, p. 1-15, 2025Tradução . . Disponível em: https://doi.org/10.1016/j.bbih.2024.100923. Acesso em: 03 ago. 2025.
APA
Hassib, L., Kanashiro, A., Pedrazzi, J. F. C., Vercesi, B. F., Higa, S., Arruda, Í., et al. (2025). Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia?: a systematic review and meta-analysis. Brain, Behavior, and Immunity - Health, 43, 1-15. doi:10.1016/j.bbih.2024.100923
NLM
Hassib L, Kanashiro A, Pedrazzi JFC, Vercesi BF, Higa S, Arruda Í, Soares Y, Souza A de J de, Jordão Junior AA, Guimarães FS, Ferreira FR. Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia?: a systematic review and meta-analysis [Internet]. Brain, Behavior, and Immunity - Health. 2025 ; 43 1-15.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.bbih.2024.100923
Vancouver
Hassib L, Kanashiro A, Pedrazzi JFC, Vercesi BF, Higa S, Arruda Í, Soares Y, Souza A de J de, Jordão Junior AA, Guimarães FS, Ferreira FR. Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia?: a systematic review and meta-analysis [Internet]. Brain, Behavior, and Immunity - Health. 2025 ; 43 1-15.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.bbih.2024.100923
Artigo de periodico
Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission (2024)
Pedrazzi, João Francisco Cordeiro; Amaral, Danyelle Silva; Issy, Ana C.; Gomes, Felipe Villela ; Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Source: Pharmacology Biochemistry and Behavior. Unidades: FMRP, FORP
Subjects: CANABINOIDES, NEUROTRANSMISSORES, ESQUIZOFRENIA, ANTIPSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior, v. 245, p. 1-9, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.pbb.2024.173879. Acesso em: 03 ago. 2025.
APA
Pedrazzi, J. F. C., Amaral, D. S., Issy, A. C., Gomes, F. V., Crippa, J. A. de S., Guimarães, F. S., & Del Bel, E. A. (2024). Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior, 245, 1-9. doi:10.1016/j.pbb.2024.173879
NLM
Pedrazzi JFC, Amaral DS, Issy AC, Gomes FV, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission [Internet]. Pharmacology Biochemistry and Behavior. 2024 ; 245 1-9.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.pbb.2024.173879
Vancouver
Pedrazzi JFC, Amaral DS, Issy AC, Gomes FV, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission [Internet]. Pharmacology Biochemistry and Behavior. 2024 ; 245 1-9.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.pbb.2024.173879
Artigo de periodico
Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers (2024)
Santos, Rafael Guimarães dos ; Dias, Isabella Caroline da Silva ; Zuardi, Antônio Waldo ; Queiroz, Regina Helena Costa; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza
Source: Journal of Clinical Psychopharmacology. Unidades: FMRP, FCFRP
Subjects: ANSIEDADE SOCIAL, ANTIDEPRESSIVOS, FÁRMACOS PSICOTRÓPICOS, PLACEBOS, ENSAIO CLÍNICO, VOLUNTARISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers. Journal of Clinical Psychopharmacology, v. 44, n. 5, p. 472-480, 2024Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001888. Acesso em: 03 ago. 2025.
APA
Santos, R. G. dos, Dias, I. C. da S., Zuardi, A. W., Queiroz, R. H. C., Guimarães, F. S., Hallak, J. E. C., & Crippa, J. A. de S. (2024). Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers. Journal of Clinical Psychopharmacology, 44( 5), 472-480. doi:10.1097/JCP.0000000000001888
NLM
Santos RG dos, Dias IC da S, Zuardi AW, Queiroz RHC, Guimarães FS, Hallak JEC, Crippa JA de S. Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers [Internet]. Journal of Clinical Psychopharmacology. 2024 ; 44( 5): 472-480.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1097/JCP.0000000000001888
Vancouver
Santos RG dos, Dias IC da S, Zuardi AW, Queiroz RHC, Guimarães FS, Hallak JEC, Crippa JA de S. Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers [Internet]. Journal of Clinical Psychopharmacology. 2024 ; 44( 5): 472-480.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1097/JCP.0000000000001888
Artigo de periodico
Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice (2024)
Moraes, Rafaela Aparecida Ponciano da Silva de; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Source: Neurotoxicity Research. Unidades: FMRP, FORP
Subjects: CANABINOIDES, MASTIGAÇÃO, NEURÓGLIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Rafaela Aparecida Ponciano da Silva de et al. Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice. Neurotoxicity Research, v. 43, n. 1, p. 1-12, 2024Tradução . . Disponível em: https://doi.org/10.1007/s12640-024-00724-0. Acesso em: 03 ago. 2025.
APA
Moraes, R. A. P. da S. de, Hallak, J. E. C., Crippa, J. A. de S., Guimarães, F. S., & Del Bel, E. A. (2024). Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice. Neurotoxicity Research, 43( 1), 1-12. doi:10.1007/s12640-024-00724-0
NLM
Moraes RAP da S de, Hallak JEC, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice [Internet]. Neurotoxicity Research. 2024 ; 43( 1): 1-12.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1007/s12640-024-00724-0
Vancouver
Moraes RAP da S de, Hallak JEC, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice [Internet]. Neurotoxicity Research. 2024 ; 43( 1): 1-12.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1007/s12640-024-00724-0
Artigo de periodico
Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study (2024)
Pinto, Jairo Vinicius Merege de Mello Cruz; Crippa, José Alexandre de Souza ; Ceresér, Keila Maria; Vianna-Sulzbach, Miréia Fortes; Silveira Júnior, Érico de Moura; Rosa, Gabriel Santana da; Silva, Manoella Guatimuzim Testa da; Hizo, Gabriel Henrique; Medeiros, Leonardo Simão; Oliveira, Carlos Eduardo Santana de; Bristot, Giovana; Campos, Alline Cristina de ; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antônio Waldo ; Yatham, Lakshmi N.; Kapczinski, Flávio; Kauer-Sant\2019anna, Márcia
Source: The Canadian Journal of Psychiatry. Unidades: FMRP, ESALQ
Subjects: TRANSTORNO BIPOLAR, HUMOR, DEPRESSÃO, CANNABIS, CANABINOIDES, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Jairo Vinicius Merege de Mello Cruz et al. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, v. 69, n. 4, p. 242-251, 2024Tradução . . Disponível em: https://doi.org/10.1177/07067437231209650. Acesso em: 03 ago. 2025.
APA
Pinto, J. V. M. de M. C., Crippa, J. A. de S., Ceresér, K. M., Vianna-Sulzbach, M. F., Silveira Júnior, É. de M., Rosa, G. S. da, et al. (2024). Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, 69( 4), 242-251. doi:10.1177/07067437231209650
NLM
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant\2019anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1177/07067437231209650
Vancouver
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant\2019anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1177/07067437231209650
Artigo de periodico
Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice (2024)
Vaz, Gabriela N.; Turcato, Flávia C.; Lima, Isabel A. V.; Scarante, Franciele F.; Araújo, Melissa Ribeiro de; Brigante, Tamires Amabile Valim ; Rodrigues, Livia C.M.; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Teixeira, Antonio L.; Oliveira, Antonio C. P.; Campos, Alline Cristina de
Source: IBRO Neuroscience Reports. Unidade: FMRP
Subjects: CAMUNDONGOS, ABLAÇÃO ANIMAL, ANTIDEPRESSIVOS, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAZ, Gabriela N. et al. Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice. IBRO Neuroscience Reports, v. 17, p. 87-95, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ibneur.2024.06.002. Acesso em: 03 ago. 2025.
APA
Vaz, G. N., Turcato, F. C., Lima, I. A. V., Scarante, F. F., Araújo, M. R. de, Brigante, T. A. V., et al. (2024). Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice. IBRO Neuroscience Reports, 17, 87-95. doi:10.1016/j.ibneur.2024.06.002
NLM
Vaz GN, Turcato FC, Lima IAV, Scarante FF, Araújo MR de, Brigante TAV, Rodrigues LCM, Guimarães FS, Hallak JEC, Crippa JA de S, Teixeira AL, Oliveira ACP, Campos AC de. Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice [Internet]. IBRO Neuroscience Reports. 2024 ; 17 87-95.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.ibneur.2024.06.002
Vancouver
Vaz GN, Turcato FC, Lima IAV, Scarante FF, Araújo MR de, Brigante TAV, Rodrigues LCM, Guimarães FS, Hallak JEC, Crippa JA de S, Teixeira AL, Oliveira ACP, Campos AC de. Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice [Internet]. IBRO Neuroscience Reports. 2024 ; 17 87-95.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.ibneur.2024.06.002
Parte de monografia/livro
Cannabidiol in anxiety disorders: current and future perspectives (2024)
Simei, João Luís Queiroz; Souza, José Diogo Ribeiro de; Lisboa, João Roberto; Guimarães, Francisco Silveira ; Crippa, José Alexandre de Souza
Source: International review of neurobiology: cannabidiol in neurology and psychiatry. Unidade: FMRP
Subjects: ANSIEDADE, CANABINOIDES, QUALIDADE DE VIDA, NEUROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMEI, João Luís Queiroz et al. Cannabidiol in anxiety disorders: current and future perspectives. International review of neurobiology: cannabidiol in neurology and psychiatry. Tradução . London: Academic Press, 2024. . Disponível em: https://doi.org/10.1016/bs.irn.2024.05.003. Acesso em: 03 ago. 2025.
APA
Simei, J. L. Q., Souza, J. D. R. de, Lisboa, J. R., Guimarães, F. S., & Crippa, J. A. de S. (2024). Cannabidiol in anxiety disorders: current and future perspectives. In International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press. doi:10.1016/bs.irn.2024.05.003
NLM
Simei JLQ, Souza JDR de, Lisboa JR, Guimarães FS, Crippa JA de S. Cannabidiol in anxiety disorders: current and future perspectives [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press; 2024. [citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.003
Vancouver
Simei JLQ, Souza JDR de, Lisboa JR, Guimarães FS, Crippa JA de S. Cannabidiol in anxiety disorders: current and future perspectives [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press; 2024. [citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.003
Trabalho de evento-resumo periodico
Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats (2024)
Mattos, Bianca Andretto de; Nascimento, Glauce Crivelaro do ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Michel, Patrick; Raisman-Vozari, Rita; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Source: IBRO Neuroscience Reports. Conference titles: World Congress of Neuroscience IBRO. Unidades: FORP, FMRP
Subjects: CANABINOIDES, DOENÇA DE PARKINSON, ANTI-INFLAMATÓRIOS, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTOS, Bianca Andretto de et al. Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats. IBRO Neuroscience Reports. Amsterdam: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.ibneur.2023.08.675. Acesso em: 03 ago. 2025. , 2024
APA
Mattos, B. A. de, Nascimento, G. C. do, Crippa, J. A. de S., Hallak, J. E. C., Michel, P., Raisman-Vozari, R., et al. (2024). Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats. IBRO Neuroscience Reports. Amsterdam: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.ibneur.2023.08.675
NLM
Mattos BA de, Nascimento GC do, Crippa JA de S, Hallak JEC, Michel P, Raisman-Vozari R, Guimarães FS, Del Bel EA. Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats [Internet]. IBRO Neuroscience Reports. 2024 ; 15 S359.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.ibneur.2023.08.675
Vancouver
Mattos BA de, Nascimento GC do, Crippa JA de S, Hallak JEC, Michel P, Raisman-Vozari R, Guimarães FS, Del Bel EA. Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats [Internet]. IBRO Neuroscience Reports. 2024 ; 15 S359.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.ibneur.2023.08.675
Artigo de periodico-carta/editorial
Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] (2023)
Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, CANNABIS, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.47626/1516-4446-2023-0047. Acesso em: 03 ago. 2025. , 2023
APA
Crippa, J. A. de S., Guimarães, F. S., Zuardi, A. W., & Hallak, J. E. C. (2023). Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.47626/1516-4446-2023-0047
NLM
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2025 ago. 03 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Vancouver
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2025 ago. 03 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Artigo de periodico
Oficina para elaboração de testes de múltipla escolha de ciências básicas aplicadas: relato de experiência (2023)
Feliciano, Cinara Silva ; Elias, Lucila Leico Kagohara ; Osako, Mariana Kiomy ; Guimarães, Francisco Silveira ; Troncon, Luiz Ernesto de Almeida ; Bollela, Valdes Roberto
Source: Revista Brasileira de Educação Médica. Unidade: FMRP
Subjects: ENSINO SUPERIOR, AVALIAÇÃO DA APRENDIZAGEM, CONHECIMENTO, CIÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FELICIANO, Cinara Silva et al. Oficina para elaboração de testes de múltipla escolha de ciências básicas aplicadas: relato de experiência. Revista Brasileira de Educação Médica, v. 47, n. 2, p. 1-7, 2023Tradução . . Disponível em: https://doi.org/10.1590/1981-5271v47.2-2022-0297. Acesso em: 03 ago. 2025.
APA
Feliciano, C. S., Elias, L. L. K., Osako, M. K., Guimarães, F. S., Troncon, L. E. de A., & Bollela, V. R. (2023). Oficina para elaboração de testes de múltipla escolha de ciências básicas aplicadas: relato de experiência. Revista Brasileira de Educação Médica, 47( 2), 1-7. doi:10.1590/1981-5271v47.2-2022-0297
NLM
Feliciano CS, Elias LLK, Osako MK, Guimarães FS, Troncon LE de A, Bollela VR. Oficina para elaboração de testes de múltipla escolha de ciências básicas aplicadas: relato de experiência [Internet]. Revista Brasileira de Educação Médica. 2023 ; 47( 2): 1-7.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1590/1981-5271v47.2-2022-0297
Vancouver
Feliciano CS, Elias LLK, Osako MK, Guimarães FS, Troncon LE de A, Bollela VR. Oficina para elaboração de testes de múltipla escolha de ciências básicas aplicadas: relato de experiência [Internet]. Revista Brasileira de Educação Médica. 2023 ; 47( 2): 1-7.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1590/1981-5271v47.2-2022-0297
Artigo de periodico
Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats (2023)
Cavichioli, Andreza M.; Silva, Thamyris Santos; Grace, Anthony A.; Guimarães, Francisco Silveira ; Gomes, Felipe Villela
Source: Schizophrenia Bulletin. Unidade: FMRP
Subjects: POTENCIAIS DE AÇÃO, NEUROTRANSMISSORES, ESQUIZOFRENIA, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVICHIOLI, Andreza M. et al. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, v. 49, n. 1, p. 68-77, 2023Tradução . . Disponível em: https://doi.org/10.1093/schbul/sbac106. Acesso em: 03 ago. 2025.
APA
Cavichioli, A. M., Silva, T. S., Grace, A. A., Guimarães, F. S., & Gomes, F. V. (2023). Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, 49( 1), 68-77. doi:10.1093/schbul/sbac106
NLM
Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1093/schbul/sbac106
Vancouver
Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1093/schbul/sbac106
Trabalho de evento-resumo periodico
Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder (2023)
Morais , Eder Roberto de; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Osório, Flávia de Lima ; Hallak, Jaime Eduardo Cecilio ; Sanches, R. F.; J. A. S. Crippa
Source: European Psychiatry. Conference titles: European Congress of Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNO OBSESSIVO-COMPULSIVO, SINTOMAS PSÍQUICOS, PSICOMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS , Eder Roberto de et al. Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder. European Psychiatry. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1192/j.eurpsy.2023.524. Acesso em: 03 ago. 2025. , 2023
APA
Morais , E. R. de, Zuardi, A. W., Guimarães, F. S., Osório, F. de L., Hallak, J. E. C., Sanches, R. F., & J. A. S. Crippa,. (2023). Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder. European Psychiatry. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1192/j.eurpsy.2023.524
NLM
Morais ER de, Zuardi AW, Guimarães FS, Osório F de L, Hallak JEC, Sanches RF, J. A. S. Crippa. Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder [Internet]. European Psychiatry. 2023 ; 66 S225-S226.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1192/j.eurpsy.2023.524
Vancouver
Morais ER de, Zuardi AW, Guimarães FS, Osório F de L, Hallak JEC, Sanches RF, J. A. S. Crippa. Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder [Internet]. European Psychiatry. 2023 ; 66 S225-S226.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1192/j.eurpsy.2023.524
Artigo de periodico
The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol (2023)
Hartmann, Alice; Vila-Verde, Carla ; Guimarães, Francisco Silveira ; Wegener, Sâmia Regiane Lourenço Joca ; Lisboa, Sabrina Francesca de Souza
Source: Current Neuropharmacology. Unidades: FMRP, FCFRP, IRI
Subjects: CANABINOIDES, INFLAMAÇÃO, TECIDO NERVOSO, DEGENERAÇÃO NEURAL, DOENÇAS DO SISTEMA NERVOSO, TRANSTORNOS PSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARTMANN, Alice et al. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, v. 21, n. 2, p. 284-308, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570159X20666220411101217. Acesso em: 03 ago. 2025.
APA
Hartmann, A., Vila-Verde, C., Guimarães, F. S., Wegener, S. R. L. J., & Lisboa, S. F. de S. (2023). The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, 21( 2), 284-308. doi:10.2174/1570159X20666220411101217
NLM
Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2025 ago. 03 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
Vancouver
Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2025 ago. 03 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
Artigo de periodico
Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors (2022)
Souza, Adriana de Jesus; Cortez, Isadora L.; Silva, Nicole R.; Pedrazzi, João Francisco Cordeiro; Domingos, Luana B.; Braga, Matheus Silva; Silva, Thamyris Santos; Del Bel, Elaine Aparecida ; Resstel, Leonardo Barbosa Moraes ; Li, Guanguan; Mian, Md Yeunus; Sharmin, Dishary; Guimarães, Francisco Silveira ; Cook, James M.; Gomes, Felipe Villela
Source: Behavioural Brain Research. Unidades: FORP, FMRP
Subjects: ANSIEDADE, DEPRESSÃO, ANTIPSICÓTICOS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Adriana de Jesus et al. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, v. 428, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2022.113832. Acesso em: 03 ago. 2025.
APA
Souza, A. de J., Cortez, I. L., Silva, N. R., Pedrazzi, J. F. C., Domingos, L. B., Braga, M. S., et al. (2022). Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, 428, 1-11. doi:10.1016/j.bbr.2022.113832
NLM
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Vancouver
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Artigo de periodico
Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) (2022)
Souza, José Diogo Ribeiro de; Pacheco, Júlia Cozar; Rossi, Giordano Novak ; Paulo, Bruno O. de; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Santos, Rafael Guimarães dos
Source: Pharmaceutics. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE MEDICAMENTOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, José Diogo Ribeiro de et al. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022). Pharmaceutics, v. 14, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14122598. Acesso em: 03 ago. 2025.
APA
Souza, J. D. R. de, Pacheco, J. C., Rossi, G. N., Paulo, B. O. de, Zuardi, A. W., Guimarães, F. S., et al. (2022). Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022). Pharmaceutics, 14, 1-14. doi:10.3390/pharmaceutics14122598
NLM
Souza JDR de, Pacheco JC, Rossi GN, Paulo BO de, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA de S, Santos RG dos. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) [Internet]. Pharmaceutics. 2022 ; 14 1-14.[citado 2025 ago. 03 ] Available from: https://doi.org/10.3390/pharmaceutics14122598
Vancouver
Souza JDR de, Pacheco JC, Rossi GN, Paulo BO de, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA de S, Santos RG dos. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) [Internet]. Pharmaceutics. 2022 ; 14 1-14.[citado 2025 ago. 03 ] Available from: https://doi.org/10.3390/pharmaceutics14122598
Artigo de periodico
Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters (2022)
Crippa, José Alexandre de Souza ; Pereira Junior, Luiz C.; Pereira, Lívia C.; Zimmermann, Patrícia M.; Brum Júnior, Liberato; Rechia, Letícia Mello; Dias, Isabella Caroline da Silva; Hallak, Jaime Eduardo Cecilio ; Campos, Alline Cristina de; Guimarães, Francisco Silveira ; Queiroz, Regina Helena Costa; Zuardi, Antonio Waldo
Source: Brazilian Journal of Psychiatry. Unidades: FMRP, FCFRP
Subjects: CANABINOIDES, FARMACOTERAPIA, FARMACODINÂMICA, MÉTODO DUPLO-CEGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters. Brazilian Journal of Psychiatry, v. 44, n. 1, p. 15-20, 2022Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2020-1684. Acesso em: 03 ago. 2025.
APA
Crippa, J. A. de S., Pereira Junior, L. C., Pereira, L. C., Zimmermann, P. M., Brum Júnior, L., Rechia, L. M., et al. (2022). Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters. Brazilian Journal of Psychiatry, 44( 1), 15-20. doi:10.1590/1516-4446-2020-1684
NLM
Crippa JA de S, Pereira Junior LC, Pereira LC, Zimmermann PM, Brum Júnior L, Rechia LM, Dias IC da S, Hallak JEC, Campos AC de, Guimarães FS, Queiroz RHC, Zuardi AW. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters [Internet]. Brazilian Journal of Psychiatry. 2022 ; 44( 1): 15-20.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1590/1516-4446-2020-1684
Vancouver
Crippa JA de S, Pereira Junior LC, Pereira LC, Zimmermann PM, Brum Júnior L, Rechia LM, Dias IC da S, Hallak JEC, Campos AC de, Guimarães FS, Queiroz RHC, Zuardi AW. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters [Internet]. Brazilian Journal of Psychiatry. 2022 ; 44( 1): 15-20.[citado 2025 ago. 03 ] Available from: https://doi.org/10.1590/1516-4446-2020-1684
Artigo de periodico
Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity (2022)
Carvalho, Renata K.; Rocha, Thiago L.; Fernandes, Fábio H.; Gonçalves, Bruno B.; Souza, Maingredy R.; Araújo, Amanda A.; Barbosa, Caio C.; Silva, Daniela M.; Campos, Hericles M.; Tomazett, Mariana V.; Ghedini, Paulo C.; Guimarães, Francisco Silveira ; Andersen, Monica L.; Santos, Fernanda C. A.; Costa, Renata Mazaro
Source: Chemico-Biological Interactions. Unidades: FMRP, FCF
Subjects: CANABINOIDES, DANO AO DNA, ESPERMATOGÊNESE, ESPERMATOZOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Renata K. et al. Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity. Chemico-Biological Interactions, v. 351, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2021.109743. Acesso em: 03 ago. 2025.
APA
Carvalho, R. K., Rocha, T. L., Fernandes, F. H., Gonçalves, B. B., Souza, M. R., Araújo, A. A., et al. (2022). Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity. Chemico-Biological Interactions, 351. doi:10.1016/j.cbi.2021.109743
NLM
Carvalho RK, Rocha TL, Fernandes FH, Gonçalves BB, Souza MR, Araújo AA, Barbosa CC, Silva DM, Campos HM, Tomazett MV, Ghedini PC, Guimarães FS, Andersen ML, Santos FCA, Costa RM. Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity [Internet]. Chemico-Biological Interactions. 2022 ; 351[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.cbi.2021.109743
Vancouver
Carvalho RK, Rocha TL, Fernandes FH, Gonçalves BB, Souza MR, Araújo AA, Barbosa CC, Silva DM, Campos HM, Tomazett MV, Ghedini PC, Guimarães FS, Andersen ML, Santos FCA, Costa RM. Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity [Internet]. Chemico-Biological Interactions. 2022 ; 351[citado 2025 ago. 03 ] Available from: https://doi.org/10.1016/j.cbi.2021.109743
Artigo de periodico
Case report: cannabidiol-induced skin rash: a case series and key recommendations (2022)
Souza, José Diogo dos Santos; Fassoni-Ribeiro, Maíra; Batista, Rayssa Miranda; Ushirohira, Juliana Mayumi; Zuardi, Antonio Waldo; Guimarães, Francisco Silveira ; Campos, Alline Cristina de; Osório, Flávia de Lima ; Elias, Daniel; Souza, Cacilda da Silva; Fassoni, Andréa Aparecida; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE MEDICAMENTOS, FERIMENTOS E LESÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, José Diogo dos Santos et al. Case report: cannabidiol-induced skin rash: a case series and key recommendations. Frontiers in Pharmacology, v. 13, p. 1-6, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.881617. Acesso em: 03 ago. 2025.
APA
Souza, J. D. dos S., Fassoni-Ribeiro, M., Batista, R. M., Ushirohira, J. M., Zuardi, A. W., Guimarães, F. S., et al. (2022). Case report: cannabidiol-induced skin rash: a case series and key recommendations. Frontiers in Pharmacology, 13, 1-6. doi:10.3389/fphar.2022.881617
NLM
Souza JD dos S, Fassoni-Ribeiro M, Batista RM, Ushirohira JM, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Elias D, Souza C da S, Fassoni AA, Hallak JEC, Crippa JA de S. Case report: cannabidiol-induced skin rash: a case series and key recommendations [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-6.[citado 2025 ago. 03 ] Available from: https://doi.org/10.3389/fphar.2022.881617
Vancouver
Souza JD dos S, Fassoni-Ribeiro M, Batista RM, Ushirohira JM, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Elias D, Souza C da S, Fassoni AA, Hallak JEC, Crippa JA de S. Case report: cannabidiol-induced skin rash: a case series and key recommendations [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-6.[citado 2025 ago. 03 ] Available from: https://doi.org/10.3389/fphar.2022.881617
Artigo de periodico
Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice (2022)
Ribeiro, Melissa A.; Aguiar, Rafael P.; Scarante, Franciele Franco ; Fusse, Eduardo J.; Oliveira, Rubia M. W. de; Guimarães, Francisco Silveira ; Campos, Alline Cristina de
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: ESTRESSE, ANTIDEPRESSIVOS, HIPOCAMPO, COMPORTAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Melissa A. et al. Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice. Frontiers in Pharmacology, v. 12, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.805758. Acesso em: 03 ago. 2025.
APA
Ribeiro, M. A., Aguiar, R. P., Scarante, F. F., Fusse, E. J., Oliveira, R. M. W. de, Guimarães, F. S., & Campos, A. C. de. (2022). Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice. Frontiers in Pharmacology, 12, 1-14. doi:10.3389/fphar.2021.805758
NLM
Ribeiro MA, Aguiar RP, Scarante FF, Fusse EJ, Oliveira RMW de, Guimarães FS, Campos AC de. Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-14.[citado 2025 ago. 03 ] Available from: https://doi.org/10.3389/fphar.2021.805758
Vancouver
Ribeiro MA, Aguiar RP, Scarante FF, Fusse EJ, Oliveira RMW de, Guimarães FS, Campos AC de. Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-14.[citado 2025 ago. 03 ] Available from: https://doi.org/10.3389/fphar.2021.805758
Artigo de periodico
Inducible nitric oxide synthase inhibition in the medial prefrontal cortex attenuates the anxiogenic-like effect of acute restraint stress via CB1 receptors (2022)
Coelho, Arthur Alves ; Vila-Verde, Carla; Sartim, Ariandra Guerini; Uliana, Daniela Lescano Martins ; Braga, Laura Arantes; Guimarães, Francisco Silveira ; Lisboa, Sabrina Francesca de Souza
Source: Frontiers in Psychiatry. Unidades: FMRP, FCFRP
Subjects: CANABINOIDES, RECEPTORES, CÓRTEX PRÉ-FRONTAL, ANSIEDADE, ESTRESSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Arthur Alves et al. Inducible nitric oxide synthase inhibition in the medial prefrontal cortex attenuates the anxiogenic-like effect of acute restraint stress via CB1 receptors. Frontiers in Psychiatry, v. 13, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2022.923177. Acesso em: 03 ago. 2025.
APA
Coelho, A. A., Vila-Verde, C., Sartim, A. G., Uliana, D. L. M., Braga, L. A., Guimarães, F. S., & Lisboa, S. F. de S. (2022). Inducible nitric oxide synthase inhibition in the medial prefrontal cortex attenuates the anxiogenic-like effect of acute restraint stress via CB1 receptors. Frontiers in Psychiatry, 13, 1-11. doi:10.3389/fpsyt.2022.923177
NLM
Coelho AA, Vila-Verde C, Sartim AG, Uliana DLM, Braga LA, Guimarães FS, Lisboa SF de S. Inducible nitric oxide synthase inhibition in the medial prefrontal cortex attenuates the anxiogenic-like effect of acute restraint stress via CB1 receptors [Internet]. Frontiers in Psychiatry. 2022 ; 13 1-11.[citado 2025 ago. 03 ] Available from: https://doi.org/10.3389/fpsyt.2022.923177
Vancouver
Coelho AA, Vila-Verde C, Sartim AG, Uliana DLM, Braga LA, Guimarães FS, Lisboa SF de S. Inducible nitric oxide synthase inhibition in the medial prefrontal cortex attenuates the anxiogenic-like effect of acute restraint stress via CB1 receptors [Internet]. Frontiers in Psychiatry. 2022 ; 13 1-11.[citado 2025 ago. 03 ] Available from: https://doi.org/10.3389/fpsyt.2022.923177

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration